Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
Bultitude WP, Schellekens J, Szydlo RM, Anthias C, Cooley SA, Miller JS, Weisdorf DJ, Shaw BE, Roberts CH, Garcia-Sepulveda CA, Lee J, Pearce RM, Wilson MC, Potter MN, Byrne JL, Russell NH, MacKinnon S, Bloor AJ, Patel A, McQuaker IG, Malladi R, Tholouli E, Orchard K, Potter VT, Madrigal JA, Mayor NP, Marsh SGE.
Bultitude WP, et al. Among authors: lee j.
Bone Marrow Transplant. 2020 Oct;55(10):1975-1984. doi: 10.1038/s41409-020-0858-9. Epub 2020 Mar 13.
Bone Marrow Transplant. 2020.
PMID: 32203258
Free PMC article.